Abstract:Casticin, a polymethoxyflavone occurring in natural plants, has been shown to have anticancer activities. In the present study, we aims to investigate the anti-skin cancer activity of casticin on melanoma cells in vitro and the antitumor effect of casticin on human melanoma xenografts in nu/nu mice in vivo. A flow cytometric assay was performed to detect expression of viable cells, cell cycles, reactive oxygen species production, levels of [Formula: see text] and caspase activity. A Western blotting assay and confocal laser microscope examination were performed to detect expression of protein levels. In the in vitro studies, we found that casticin induced morphological cell changes and DNA condensation and damage, decreased the total viable cells, and induced G2/M phase arrest. Casticin promoted reactive oxygen species (ROS) production, decreased the level of [Formula: see text], and promoted caspase-3 activities in A375.S2 cells. The induced G2/M phase arrest indicated by the Western blotting assay showed that casticin promoted the expression of p53, p21 and CHK-1 proteins and inhibited the protein levels of Cdc25c, CDK-1, Cyclin A and B. The casticin-induced apoptosis indicated that casticin promoted pro-apoptotic proteins but inhibited anti-apoptotic proteins. These findings also were confirmed by the fact that casticin promoted the release of AIF and Endo G from mitochondria to cytosol. An electrophoretic mobility shift assay (EMSA) assay showed that casticin inhibited the NF-[Formula: see text]B binding DNA and that these effects were time-dependent. In the in vivo studies, results from immuno-deficient nu/nu mice bearing the A375.S2 tumor xenograft indicated that casticin significantly suppressed tumor growth based on tumor size and weight decreases. Early G2/M arrest and mitochondria-dependent signaling contributed to the apoptotic A375.S2 cell demise induced by casticin. In in vivo experiments, A375.S2 also efficaciously suppressed tumor volume in a xenotransplantation model. Therefore, casticin might be a potential therapeutic agent for the treatment of skin cancer in the future.

Casticin, a Flavonoid, Potentiates TRAIL-induced Apoptosis Through Modulation of Anti-Apoptotic Proteins and Death Receptor 5 in Colon Cancer Cells.

Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells.

Apoptosis Was Induced by Casticin in Acute Myelocytic Leukemia Cells

Casticin induces leukemic cell death through apoptosis and mitotic catastrophe

Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells Through the Inhibition of NF-κB and Mitochondria-Dependent Pathways in Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model in Vivo

Casticin Induces Apoptosis and G0/G1 Cell Cycle Arrest in Gallbladder Cancer Cells

The role of casticin in the apoptosis of pancreatic cancer cells and its mechanism

Casticin impairs cell growth and induces cell apoptosis via cell cycle arrest in human oral cancer SCC-4 cells.

Casticin inhibits the hedgehog signaling and leads to apoptosis in AML stem-like KG1a and mature KG1 cells

Casticin Induces DNA Damage and Inhibits DNA Repair-Associated Protein Expression in B16F10 Mouse Melanoma Cancer Cells.

Casticin Induces DNA Damage and Affects DNA Repair Associated Protein Expression in Human Lung Cancer A549 Cells (Running Title: Casticin Induces DNA Damage in Lung Cancer Cells)

Casticin Inhibits Human Prostate Cancer DU 145 Cell Migration and Invasion Via Ras/Akt/NF-κB Signaling Pathways.

Casticin Impairs Cell Migration and Invasion of Mouse Melanoma B16F10 Cells Via PI3K/AKT and NF‐κB Signaling Pathways

Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion Through Downregulating NF-κB and Matrix Metalloproteinase-2 and -1.

Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells

Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway

Casticin Promotes Immune Responses, Enhances Macrophage and NK Cell Activities, and Increases Survival Rates of Leukemia BALB/c Mice.

Casticin elicits inflammasome-induced pyroptosis through activating PKR/JNK/NF-B signal in 5-8F cells

CCT327 enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cell survival proteins in TRAIL-resistant human leukemia cells.

Casticin Prevents DSS Induced Ulcerative Colitis in Mice Through Inhibitions of NF‐κB Pathway and ROS Signaling

Casticin Suppresses the Carcinogenesis of Small Cell Lung Cancer H446 Cells Through Activation of AMPK/FoxO3a Signaling.